CKD benefits were similar, with the FLOW trial (3,500 patients with T2D and chronic kidney disease), Semaglutide (1 mg weekly) reduced the risk of kidney failure events and death from kidney- or cardiovascular-related causes by 24% (HR 0.76
If you start developing more bruises or discover your gums are bleeding, you may have thrombocytopenia or hemophilia, two conditions that make it difficult for your blood to clot
Abbreviations ADA: American Diabetes Association ANVISA: Brazilian Health Regulatory Agency BMI: Body mass index CI: Confidence interval CKD: Chronic kidney disease CV: Cardiovascular CVD: Cardiovascular disease EASD: European Association for the Study of Diabetes eGFR: Estimated glomerular filtration rate ETD: Estimated treatment difference FDA: Food and Drug Administration GI: Gastrointestinal GLP-1 RA: Glucagon-like peptide 1 receptor agonist HbA1c: Glycated hemoglobin HOMA-: Homeostasis model assessment of -cell function HR: Hazard ratio kg: Kilograms kJ: Kilojoules m: Meter MACE: Major adverse cardiovascular event mg: Milligrams OR: Odds ratios PIONEER: Peptide Innovation for Early Diabetes Treatment SGLT2i: Sodium-glucose cotransporter 2 inhibitor SNAC: Sodium N-[8-(2-hydroxybenzoyl) amino] caprylate T2D: Type 2 diabetes TZD: Thiazolidinedione UKPDS: United Kingdom Prospective Diabetes Study References International Diabetes Federation
S-Acetyl-glutathione as a promising oral form of glutathione: bioavailability and intracellular delivery. Medical Hypotheses
For people with type 2 diabetes who also use insulin or insulin-stimulating medications, the risk of low blood sugar, also called hypoglycemia, can increase, and the dose of those medicines may need to be lowered
